CollPlant Biotechnologies (CLGN) Income from Non-Controlling Interests (2018 - 2019)
CollPlant Biotechnologies (CLGN) posted Income from Non-Controlling Interests of $4.4 million for Q4 2019, up 36.87% on a QoQ basis from $3.2 million in Q3 2019, and up 183.18% year-over-year from $1.6 million in Q4 2018.
CollPlant Biotechnologies (CLGN) Income from Non-Controlling Interests (2018 - 2019) Analysis & Trends
CollPlant Biotechnologies' Income from Non-Controlling Interests history runs 2 years deep, the most recent figure standing at $4.4 million for Q4 2019.
- Quarterly Income from Non-Controlling Interests rose 183.18% year-over-year to $4.4 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $11.2 million (up 64.06% YoY) and the FY2020 annual result came in at $5.8 million, down 48.28% from the prior year.
- Income from Non-Controlling Interests was $4.4 million for Q4 2019 at CollPlant Biotechnologies, up from $3.2 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $4.4 million in Q4 2019 and bottomed at $1.3 million in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | - |
| 10 | CollPlant Biotechnologies | 4.50 Mn | 4.50 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 4.40 Mn |
| Sep 30, 2019 | 3.21 Mn |
| Jun 30, 2019 | 1.52 Mn |
| Mar 31, 2019 | 2.04 Mn |
| Dec 31, 2018 | 1.55 Mn |
| Sep 30, 2018 | 1.30 Mn |
| Jun 30, 2018 | 1.72 Mn |
| Mar 31, 2018 | 2.24 Mn |